Chemotherapy used infrequently to treat patients of localized sarcoma

Written By : Hina Zahid

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2020-08-10 12:45 GMT | Update On 2020-08-10 12:46 GMT

Patients with localized soft tissue sarcoma (STS) are managed with surgery with or without radiation.

Although experts have debated the benefit of chemotherapy for people with localized sarcoma, several studies, including a recent randomized clinical trial, have demonstrated that chemotherapy can prolong the survival of patients with larger, more aggressive sarcomas. Because chemotherapy targets the cancer cells that have started escaping from the tumor and moving on to other places, such as the lungs or liver, it's often the only way to prevent or reduce the risk of the cancer spreading. Although it can cause side effects, like nausea and hair loss, chemotherapy can help prolong survival or even help cure patients of the disease.

Other studies, however, have not found a clear benefit to chemotherapy for treating localized, so there is a lack of clear guidelines on the role, number of agents or timing of chemotherapy for managing high-risk sarcoma in adults.

Using the National Cancer Database, researchers analyzed patterns of care for 19,969 adults who underwent surgery for primary high-grade soft tissue sarcoma from 2004 to 2016.

UCLA researchers have found that chemotherapy is not commonly used when treating adults with localized sarcoma, a rare type of cancer of the soft tissues or bone. In a nationwide analysis of nearly 20,000 patients whose cancer had not yet spread to other organs, the scientists learned that only 22% were treated with some form of chemotherapy.

The researchers found that even among patients with the largest and most aggressive tumors, less than half (45%) received chemotherapy. The team also found that patients were more likely to be treated with chemotherapy at facilities that perform at least 55 surgeries for sarcoma each year, versus people who received care at facilities that perform fewer such surgeries.

The study highlights the infrequent use of chemotherapy for people with sarcoma, especially at medical centers that treat fewer people with sarcoma, and it paves the way for future study on which patients might benefit most from chemotherapy as part of their treatment for sarcoma.

http://dx.doi.org/10.6004/jnccn.2020.7553

Article Source : Journal of the National Comprehensive Cancer Network

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Hina Zahid

Hina Zahid Joined Medical Dialogue in 2017 with a passion to work as a Reporter. She coordinates with various national and international journals and association and covers all the stories related to Medical guidelines, Medical Journals, rare medical surgeries as well as all the updates in the medical field. Email: editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Chemotherapy used infrequently to treat patients of localized sarcoma

Similar News

Biparametric MRI Effective as Multiparametric MRI in Detecting Prostate Cancer: Study

Millions of men could benefit from faster scan to diagnose prostate cancer: JAMA

SOX2: a key player in prostate cancer progression and treatment resistance: Study

New blood test exhibits superior sensitivity in detecting HPV-associated head and neck cancers: Study

Penile Implant Satisfaction Drops in Prostate Cancer Patients on Hormonal Treatment, reveals study

JnJ bags USFDA nod for bladder cancer treatment Inlexzo

Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

Eli lilly, Circle Pharma ink pact to further enhance AI/ML capabilities